We found that IPA, as an AHR ligand, reversed the hippocampal microglial activation and synaptic over-pruning in the IUGR rats by modulating the AHR/NF-κB signaling, thereby restoring their ASD-like symptoms. The gene discussed is AHR; the disease is fetal growth restriction.